Results

Total Results: 1,482 records

Showing results for "indications".
Users also searched for: quality indicators

81. #05 DEPRESSION (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/depression_hi_impact.pdf
    October 01, 2014 - changes would limit diffusion of DBS for MDD and OCD, possibly also minimizing access to DBS for these indications … If DBS does diffuse for these indications, it could potentially significantly change the landscape … undergo DBS to treat MDD would face risks similar to those faced by patients who undergo DBS for other indications … If approved for these separate indications, DBS is expected to be positioned as an additional second-line … However, if DBS does diffuse for these indications, it might potentially improve patient outcomes,

82. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
    January 10, 2012 - psoriasis Drug Name* Brand Name (dosage form) Marketed By (Manufacturer) Target of Therapy FDA Indications … psoriasis Drug Name* Brand Name (dosage form) Marketed By (Manufacturer) Target of Therapy FDA Indications … therapy for plaque psoriasis Drug Name* Brand Name (dosage form) Marketed By (Manufacturer) FDA Indications … of plaque psoriasis Drug Name* Brand Name (dosage form) Marketed By (Manufacturer) FDA Indications

83. Kidney-Disease-Medicine Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
    January 01, 2012 - outcomes in individuals who would not otherwise receive them; i.e., patients without specific treatment indications … In patients with other treatment indications, diagnosis of CKD or of CKD progression might be beneficial … - Prevalence in the target population of indications for and use of specific CKD treatments. … diabetes, hypertension, age, cardiovascular disease, hyperlipidemia, race/ethnicity), including possible indications

84. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-safety-practices_research-protocol.pdf
    November 09, 2011 - decision support systems (CDSS)  Bundles and checklists as a general strategy (not just for specific indications

85. Project Title: Evaluation of Suspicious Skin Lesions Using Non-Invasive Diagnostic Techniques, a Technical Brief (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_research-protocol.pdf
    August 23, 2010 - We will also examine whether there are indications of differing effectiveness among techniques for early

86. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/type-2-diabetes-medications-update_research-protocol.pdf
    April 06, 2010 - The search and protocol will be updated to include all FDA- approved drugs and indications, as of March … liraglutide, was just FDA approved in January 2010, for both mono- and combination therapy and both indications

87. Updating Current Effectiveness Reviews (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-assessment-research-updates_research.pdf
    September 15, 2008 - • Have the existing medications, procedures, or devices been approved for new indications? … Comparative Effectiveness, Safety, and Indications of Insulin Analogues in Premixed Formulations for

88. Nephropathy-Contrast-Induced Executive-2016 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_executive-2016.pdf
    January 01, 2016 - risk of CIN with different types of contrast media generally provided little detail about clinical indications … we were not able to assess whether the comparisons between types of contrast media depended on the indications

89. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-liver-metastases-therapies_research-protocol.pdf
    September 27, 2012 - Treatment Indications Two major indications for liver-directed therapies exist: 1. … This report aims to compare the effectiveness and harms of liver-directed therapies for the indications

90. Infectious Disease Including HIV/AIDS #09 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1512.pdf
    January 28, 2016 - that eliminated the need for IFN or RBV in patients with chronic HCV genotype 1 infection.32 The indications … patients infected with HCV genotype 1;32 the drug’s approval was expanded in November 2015 to include indications … FDA approves new indications for Harvoni, Gilead's once-daily single tablet regimen for chronic hepatitis … Available: http://gilead.com/news/press- releases/2015/11/us-fda-approves-new- indications-for-harvoni-gileads-oncedaily … http://gilead.com/news/press-releases/2015/11/us-fda-approves-new-indications-for-harvoni-gileads-oncedaily-single-tablet-regimen-for-chronic-hepatitis-c

91. Cervical Degenerative Disease Treatment (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cervical-degenerative-protocol.pdf
    January 12, 2022 - Challenges and controversies related to this topic include: (1) determining the indications for surgical … neuromonitoring on operative, intermediate outcomes result in improved health outcomes;15 (4) unclear indications … Surgical management of cervical degenerative disease: the evidence related to indications, impact, and

92. Comparative Effectiveness Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
    January 01, 2006 - Pharmacokinetics, Indications and Dosing of Included Drugs Drug and Trade Name (Trade names … Half-life or other relevant pharmacokinetic feature Labeled indications Dosing (oral doses) Dose … Half-life or other relevant pharmacokinetic feature Labeled indications Dosing (oral doses) Dose … Half-life or other relevant pharmacokinetic feature Labeled indications Dosing (oral doses) Dose … Pharmacokinetics, Indications and Dosing of Included Drugs Appendix B.

93. CER 217 Disposition of Comments: Management of Infertility (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-217-management-of-infertility-comments.pdf
    May 14, 2019 - “As with other indications for IVF, use of single-embryo transfer is associated with slightly lower … “As with other indications for IVF, use of single-embryo transfer is associated with slightly lower … “As with other indications for IVF, use of single-embryo transfer is associated with slightly lower … “As with other indications for IVF, use of single-embryo transfer is associated with slightly lower

94. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb-disposition.pdf
    March 10, 2010 - It may be feasible to combine studies across indications to see if there is a statistically significant … to specify different dosing regiments of ACEIs such as fosinopril, ramipril, etc. for the different indications

95. Hypertension-Pulmonary-Arterial Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypertension-pulmonary-arterial_research-protocol.pdf
    January 30, 2013 - Generic Name (if applicable) Manufacturer Dose Frequency Methods of Administration FDA Status Indications … Generic Name (if applicable) Manufacturer Dose Frequency Methods of Administration FDA Status Indications … Generic Name (if applicable) Manufacturer Dose Frequency Methods of Administration FDA Status Indications

96. #14 SUBSTANCE ABUSE (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - Standards of care for these indications remain stable; as a result, most new interventions in this … The addressed indications are doubly concerning public health issues because of the widespread availability … professional staff can identify at- risk patients based on disciplinary proceedings, hospital admission indications

97. Colorectal-Surgery-Preparation Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-surgery-preparation_research-protocol.pdf
    March 26, 2013 - adults), and indications … Studies with high risk of bias are those with indications of bias that may invalidate the reported findings … Applicability will also be judged separately for various indications of OMBP use (e.g., left-sided vs

98. Disposition of Comments for CER 168 Infantile Hemangioma (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_disposition-comments.pdf
    January 15, 2016 - important to mention that oral steroid therapy may be treatment of choice in children that have contra- indications … Discussion/ Conclusion P32: re: Harms of corticosteroids- would also note the labeled pediatric indications … Appendix H lists indications for the agents included.

99. Disposition of Comments for CER 178 Newer Medications for Lower Urinary Tract Symptoms (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/prostatic-hyperplasia-medications_disposition-comments.pdf
    May 26, 2016 - Many of the later have been approved and used for other indications for several years. … revised the sentence to clarify: “Recently, newer drugs and drug in other classes approved for other indications … Many of these have been FDA approved for other indications, but only more recently been tested for

100. Since their introduction in 20xx, DES have been shown in clinical trials to decrease TLR (… (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
     January 01, 2010 - Sixty-nine percent of DES implantations were for non-FDA-approved indications. … Drug-Eluting Stents Versus Bare-Metal Stents for Off-Label Indications: A Propensity Score- Matched … , renal status, prior revascularizations, prior MI, multivessel CAD, procedure year, and off-label indications